Expression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistance

被引：0
|
作者：
C Palmieri
O Gojis
B Rudraraju
C Stamp-Vincent
D Wilson
S Langdon
C Gourley
D Faratian
机构：
[1] Institute of translational Medicine,Department of Molecular and Clinical Cancer Medicine
[2] University of Liverpool,Division of Cancer
[3] Cancer Research UK Laboratories,Edinburgh Breakthrough Research Unit and Division of Pathology
[4] Imperial College London,undefined
[5] Du Cane Road,undefined
[6] London,undefined
[7] UK,undefined
[8] University of Edinburgh,undefined
[9] University of Edinburgh Cancer Research UK Centre,undefined
[10] Institute of Genetics and Molecular Medicine,undefined
[11] University of Edinburgh,undefined
来源：
British Journal of Cancer | 2013年 / 108卷
关键词：
ovarian cancer; SRC3; platinum; resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2039 / 2044
页数：5
相关论文
共 50 条
  • [11] Predicting platinum resistance and poor prognosis in patients with epithelial ovarian cancer Reply
    Velez, Maria P.
    Shellenberger, Jonas P.
    Ray, Joel G.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131 (09) : 1323 - 1325
  • [12] Expression of gonadotrophin releasing hormone receptor I is a favorable prognostic factor in epithelial ovarian cancer
    Wilkinson, S. J.
    Kucukmetin, A.
    Cross, P.
    Darby, S.
    Gnanapragasam, V. J.
    Calvert, A. H.
    Robson, C. N.
    Edmondson, R. J.
    HUMAN PATHOLOGY, 2008, 39 (08) : 1197 - 1204
  • [13] M-cam expression as marker of poor prognosis in epithelial ovarian cancer
    Aldovini, Daniela
    Demichelis, Francesca
    Doglioni, Claudio
    Di Vizio, Dolores
    Galligioni, Enzo
    Brugnara, Sonia
    Zeni, Bruna
    Griso, Claudia
    Pegoraro, Cristina
    Zannoni, Marina
    Gariboldi, Manuela
    Balladore, Emanuela
    Mezzanzanica, Delia
    Canevari, Silvana
    Barbareschi, Mattia
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (08) : 1920 - 1926
  • [14] Association of Copper Transporter Expression with Platinum Resistance in Epithelial Ovarian Cancer
    Yoshida, Hiroyuki
    Teramae, Masatomo
    Yamauchi, Makoto
    Fukuda, Takeshi
    Yasui, Tomoyo
    Sumi, Toshiyuki
    Honda, Ken-Ichi
    Ishiko, Osamu
    ANTICANCER RESEARCH, 2013, 33 (04) : 1409 - 1414
  • [15] Phosphorylation of Steroid Receptor Coactivator 3 (SRC3) at Ser543 is a novel independent prognostic marker in breast cancer
    Palmieri, C.
    Gojis, O.
    Rudraraju, B.
    Abdel-Fatah, T. M. A.
    Moore, D.
    Shaw, J.
    Green, A.
    Ellis, I. O.
    Coombes, R. C.
    Ali, S.
    CANCER RESEARCH, 2012, 72
  • [16] Platelet-Derived Growth Factor D Is a Prognostic Biomarker and Is Associated With Platinum Resistance in Epithelial Ovarian Cancer
    Zhang, Mengjun
    Liu, Tianbo
    Xia, Bairong
    Yang, Chunyan
    Hou, Siyu
    Xie, Wanlin
    Lou, Ge
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (02) : 323 - 331
  • [17] Expression of Receptor Activator of Nuclear Factor Kappa-B as a Poor Prognostic Marker in Breast Cancer
    Park, Hyung Seok
    Lee, Ahwon
    Chae, Byung Joo
    Bae, Ja-Seong
    Song, Byung Joo
    Jung, Sang Seol
    JOURNAL OF SURGICAL ONCOLOGY, 2014, 110 (07) : 807 - 812
  • [18] Expression patterns of the steroid receptor coactivator family in human ovarian endometriosis
    Kumagami, Atsuko
    Ito, Akiko
    Yoshida-Komiya, Hiromi
    Fujimori, Keiya
    Sato, Akira
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2011, 37 (10) : 1269 - 1276
  • [19] Short androgen receptor allele length is a poor prognostic factor in epithelial ovarian carcinoma
    Li, AJ
    Baldwin, RL
    Karlan, BY
    CLINICAL CANCER RESEARCH, 2003, 9 (10) : 3667 - 3673
  • [20] Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer
    Jonna Berntsson
    Sebastian Lundgren
    Björn Nodin
    Mathias Uhlén
    Alexander Gaber
    Karin Jirström
    Journal of Ovarian Research, 7
12345